0001209191-23-043005.txt : 20230720
0001209191-23-043005.hdr.sgml : 20230720
20230720214603
ACCESSION NUMBER: 0001209191-23-043005
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230720
FILED AS OF DATE: 20230720
DATE AS OF CHANGE: 20230720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P.
CENTRAL INDEX KEY: 0001589095
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100961
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V, L.P.
CENTRAL INDEX KEY: 0001589097
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100963
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P.
CENTRAL INDEX KEY: 0001589098
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100962
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP
CENTRAL INDEX KEY: 0001612235
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100958
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V GP-GP (Canada), Inc.
CENTRAL INDEX KEY: 0001619297
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100960
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2215
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Vantage II GP, L.P.
CENTRAL INDEX KEY: 0001839790
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100956
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V (Canada), L.P.
CENTRAL INDEX KEY: 0001716490
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100959
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (650) 843-5000
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures V, LLC
CENTRAL INDEX KEY: 0001619298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100964
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2215
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Vantage II, L.P.
CENTRAL INDEX KEY: 0001832235
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100955
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Vantage II GP-GP, LLC
CENTRAL INDEX KEY: 0001839789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231100957
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turnstone Biologics Corp.
CENTRAL INDEX KEY: 0001764974
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832909368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 347-897-5988
MAIL ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-07-20
0
0001764974
Turnstone Biologics Corp.
TSBX
0001619298
Versant Ventures V, LLC
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001589097
Versant Venture Capital V, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001589098
Versant Ophthalmic Affiliates I, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001589095
Versant Affiliates Fund V, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001619297
Versant Ventures V GP-GP (Canada), Inc.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001716490
Versant Ventures V (Canada), L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001612235
Versant Venture Capital V (Canada), LP
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001839789
Versant Vantage II GP-GP, LLC
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001839790
Versant Vantage II GP, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
0001832235
Versant Vantage II, L.P.
ONE SANSOME STREET, SUITE 1650
SAN FRANCISCO
CA
94104
0
0
1
0
Series A Preferred Stock
Common Stock
988832
I
By Versant Venture Capital V, L.P.
Series A Preferred Stock
Common Stock
75255
I
By Versant Venture Capital V (Canada) LP
Series A Preferred Stock
Common Stock
32971
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series A Preferred Stock
Common Stock
29744
I
By Versant Affiliates Fund V, L.P.
Series B-1 Preferred Stock
Common Stock
442055
I
By Versant Venture Capital V, L.P.
Series B-1 Preferred Stock
Common Stock
33642
I
By Versant Venture Capital V (Canada) LP
Series B-1 Preferred Stock
Common Stock
14739
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series B-1 Preferred Stock
Common Stock
13297
I
By Versant Affiliates Fund V, L.P.
Series B-2 Preferred Stock
Common Stock
957787
I
By Versant Venture Capital V, L.P.
Series B-2 Preferred Stock
Common Stock
72892
I
By Versant Venture Capital V (Canada) LP
Series B-2 Preferred Stock
Common Stock
31936
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series B-2 Preferred Stock
Common Stock
28810
I
By Versant Affiliates Fund V, L.P.
Series C Preferred Stock
Common Stock
140190
I
By Versant Venture Capital V, L.P.
Series C Preferred Stock
Common Stock
10669
I
By Versant Venture Capital V (Canada) LP
Series C Preferred Stock
Common Stock
4667
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series C Preferred Stock
Common Stock
4216
I
By Versant Affiliates Fund V, L.P.
Series D Preferred Stock
Common Stock
274990
I
By Versant Vantage II, L.P.
Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock will automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
Shares are held by Versant Venture Capital V, L.P. ("Versant V"). Versant Ventures V, LLC ("Versant V GP") is the sole general partner of Versant V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.
Shares are held by Versant Venture Capital V (Canada) LP ("Canada V"). Versant Ventures V (Canada), L.P. ("Canada V GP") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. ("Canada V GP-GP") is the sole general partner of Canada V GP. Jerel C. Davis is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.
Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. ("Ophthalmic"). Versant V GP is the sole general partner of Ophthalmic. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.
Shares are held by Versant Affiliates Fund V, L.P. ("Affiliates V"). Versant V GP is the sole general partner of Affiliates V. Jerel C. Davis is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Affiliates, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.
Shares held by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP") is the sole general partner of Vantage II GP. Jerel C. Davis is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. Each of the Reporting Persons disclaims beneficial ownership of the shares held by Canada V, except to the extent of its respective pecuniary interest therein. Dr. Davis is a director of the Issuer and files separate Section 16 reports.
Versant Ventures V, LLC, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Venture Capital V, L.P., By Versant Ventures V, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Ophthalmic Affiliates Fund I, L.P., By Versant Ventures V, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Affiliates Fund V, L.P., By Versant Ventures V, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Ventures V GP-GP (Canada), Inc., By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Ventures V (Canada), L.P., By Versant Ventures V GP-GP (Canada), Inc., its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Venture Capital V (Canada), LP, By Versant Ventures V (Canada), L.P., its general partner, By Versant Ventures V GP-GP (Canada), Inc., its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Vantage II GP-GP, LLC, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Vantage II GP, L.P., By Versant Vantage II GP-GP, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20
Versant Vantage II, L.P., By Versant Vantage II GP, L.P., its general partner, By Versant Vantage II GP-GP, LLC, its general partner, By /s/ Max Eisenberg, Chief Operating Officer
2023-07-20